当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 资产负债表

康辰药业

(603590)

  

流通市值:84.73亿  总市值:85.77亿
流通股本:1.57亿   总股本:1.59亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金366,314,713.38212,131,620.11189,977,701.84307,759,615.46
  交易性金融资产391,050,361.08390,849,333.32450,662,375.93332,555,610.34
  应收票据及应收账款345,252,441.13302,722,762.67251,013,321.48289,160,633.42
        应收账款345,252,441.13302,722,762.67251,013,321.48289,160,633.42
  应收款项融资4,275,154.974,328,518.66,363,2885,720,828.48
  预付款项11,889,335.149,745,892.94,712,451.0228,771,043.44
  其他应收款合计32,803,577.5433,796,59833,841,304.8634,391,717.72
  存货69,521,027.1269,870,047.2172,383,172.3460,894,611.23
  其他流动资产156,443,276.99168,930,402.2577,586,421.5875,360,368.27
  流动资产合计1,377,549,887.351,192,375,175.061,086,540,037.051,134,614,428.36
非流动资产:
  长期股权投资48,610,808.3249,141,244.0849,322,264.2949,170,120.57
  其他权益工具投资696,604,008.15703,359,892.89748,399,124.49740,514,803.77
  其他非流动金融资产88,253,178.3688,083,749.0188,804,516.5574,323,507
  固定资产191,098,987193,589,225.97199,173,514.04205,001,305.39
  在建工程216,114,155.24217,857,179.85209,845,880.18209,105,161.76
  生产性生物资产362,500400,000437,500-
  使用权资产12,536,449.4215,531,822.7817,275,950.9419,020,079.09
  无形资产838,008,635.73840,040,613.57842,667,929.51848,022,890.3
  开发支出263,629,184.63248,557,598.83233,770,135.29194,885,624.65
  商誉---97,642,801.5
  长期待摊费用495,378.32547,669.74587,961.17640,877.59
  递延所得税资产21,806,951.7824,766,826.4927,465,038.7421,043,408.33
  其他非流动资产116,745,575.43310,917,356.75415,399,038.2402,071,309.8
  非流动资产合计2,494,265,812.382,692,793,179.962,833,148,853.42,861,441,889.75
  资产总计3,871,815,699.733,885,168,355.023,919,688,890.453,996,056,318.11
流动负债:
  短期借款182,390,695.81159,739,719.5140,955,196.27103,045,986.7
  应付票据及应付账款51,592,173.0751,283,103.8773,569,212.7598,437,923.84
        应付账款51,592,173.0751,283,103.8773,569,212.7598,437,923.84
  合同负债2,354,059.343,325,933.916,426,596.762,191,802.84
  应付职工薪酬27,962,295.9820,939,151.5343,685,764.123,740,119.54
  应交税费11,977,452.287,124,639.318,880,929.217,755,065.87
  其他应付款合计48,075,538.862,192,968.4371,082,843.4468,089,436.42
  一年内到期的非流动负债9,123,866.998,138,084.098,071,679.0916,185,194.97
  其他流动负债47,380.1221,561.1710,993.6425,339.86
  流动负债合计333,523,462.39312,765,161.81352,683,215.26319,470,870.04
非流动负债:
  长期借款55,574,71249,576,40949,845,80985,451,506
  租赁负债6,564,0088,980,667.3410,800,404.4212,551,921.2
  递延收益38,623,037.939,549,246.5140,475,455.1420,706,963.76
  递延所得税负债31,718,308.2134,632,686.7539,720,009.8740,461,525.14
  非流动负债合计132,480,066.11132,739,009.6140,841,678.43159,171,916.1
  负债合计466,003,528.5445,504,171.41493,524,893.69478,642,786.14
所有者权益(或股东权益):
  实收资本(或股本)159,356,477159,356,477159,356,477160,000,000
  资本公积950,547,293.83948,240,986.8944,595,003.46959,952,197.71
  减:库存股19,192,99035,927,57035,927,57055,923,616.53
  其他综合收益-12,230,834.16-6,488,332.1331,795,014.7325,093,342.11
  盈余公积80,000,00080,000,00080,000,00080,000,000
  未分配利润1,960,291,997.32,009,090,794.281,964,593,400.482,035,305,885.97
  归属于母公司股东权益合计3,118,771,943.973,154,272,355.953,144,412,325.673,204,427,809.26
  少数股东权益287,040,227.26285,391,827.66281,751,671.09312,985,722.71
  股东权益合计3,405,812,171.233,439,664,183.613,426,163,996.763,517,413,531.97
  负债和股东权益合计3,871,815,699.733,885,168,355.023,919,688,890.453,996,056,318.11
公告日期2025-08-282025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑